Adalimumab: Demyelinating disorder: case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1112, 2006-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab: Demyelinating encephalomyelitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1317, 2010-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Infliximab: Demyelinating disorder: case report

By  

Reactions Weekly, Vol. 1, Iss. 1100, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Adalimumab: Psoriasis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1249, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Adalimumab: Urticaria: case report

By  

Reactions Weekly, Vol. 1, Iss. 1169, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Adalimumab: Encephalomyelitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1179, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite